{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "country": "United States",
      "city": "Irvine",
      "address_1": "35 Hammond",
      "reason_for_recall": "Endologix updated the Instructions for Use (IFU) and implemented modifications to the AFX Endovascular  AAA System (AFX System).",
      "address_2": "",
      "product_quantity": "40967",
      "code_info": "The correction is not lot specific. It applies to AFX procedures conducted after July 2015",
      "center_classification_date": "20170118",
      "distribution_pattern": "US and worldwide:     Austria, Belgium, Czech Republic, France, Germany, Greece, Ireland, Israel, Italy, Latvia, Luxembourg, Monaco, Netherlands, Poland, Portugal, Spain, Sweden, Switzerland, Turkey, United Kingdom.",
      "state": "CA",
      "product_description": "AFX Endovascular AAA System, Endoleak Type IIIB;  The AFX Endovascular AAA System is intended for endovascular treatment of patients with abdominal aortic or aortoiliac aneurysms (AAA).",
      "report_date": "20170125",
      "classification": "Class II",
      "openfda": {},
      "recalling_firm": "Endologix",
      "recall_number": "Z-1038-2017",
      "initial_firm_notification": "Letter",
      "product_type": "Devices",
      "event_id": "76110",
      "termination_date": "20170428",
      "more_code_info": "",
      "recall_initiation_date": "20161227",
      "postal_code": "92618-1607",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "status": "Terminated"
    }
  ]
}